Brief: Exosens Shareholder HLD Europe Sells 9.8% Stake In Company to Theon International
Oct 14 (Reuters) - Exosens SAS EXENS.PA: HLD EUROPE ENTERED INTO AN AGREEMENT WITH THEON INTERNATIONAL, THE GROUP’S MAIN CUSTOMER, FOR THE SALE OF 9.8% OF EXOSENS’ SHARE AT A PRICE OF €54 PER SHARE COMPLETION OF THE TRANSACTION, WHICH REMAINS SUBJECT TO VARIOUS REGULATORY NOTIFICATIONS, IS EXPECTED TO TAKE PLACE IN EARLY Q1 2026 Further company coverage: EXENS.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Theon International
See all newsBrief: Theon International Wins Night Vision Contracts Worth EUR 45 Mln From Two European NATO States
Brief: Theon Secures New Orders Of Around €50 Mln To Supply Nyx, Orion Goggles
French and Benelux stocks-Factors to watch
Brief: Theon International Q2 Revenue At €128.6 Mln
Brief: Theon International Enters Exclusivity Agreement To Buy HGH For €300 Mln Enterprise Value